Aurora Therapeutics is developing a new approach to gene editing for rare diseases by leveraging the FDA’s emerging “plausible mechanism” regulatory pathway. The company was…
January 09, 2026
Aurora Therapeutics is developing a new approach to gene editing for rare diseases by leveraging the FDA’s emerging “plausible mechanism” regulatory pathway. The company was…